antibody

Documents about antibody

• Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer#6868OpenAlex
• Cytomegalovirus serostatus and plasma MCP-1 levels are associated with antibody response to seasonal influenza vaccine across age and sex#13897bioRxiv / medRxiv
• Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.#25594NCBI PubMed Central
• Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy#146265ClinicalTrials.gov
• Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection#148794ClinicalTrials.gov
• LM-QASAS: Reference-free identification of antigen-specific sequences from the BCR repertoire using antibody language models#149871Unpaywall
• Testing the capacity of humanized immune system mice to induce a protective antibody response against the Lyme disease pathogen.#157015NCBI PubMed Central
• Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients#211643Ora Oxford University Research
• Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management.#247626NCBI PubMed Central
• PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer#253000ClinicalTrials.gov
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer#253066ClinicalTrials.gov
• Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults#279554ClinicalTrials.gov
• Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI.#285319NCBI PubMed Central
• Soluble CD95L triggers Caspase-10-driven reactive oxygen species production in neutrophils and aggravates anti-neutrophil cytoplasmic antibody-vasculitis#301082HAL (France)
• Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine#314381ClinicalTrials.gov
• TNFRSF13B Common Variants Enhance Antibody-Dependent Complement Activation and Susceptibility to Acute Respiratory Distress Syndrome Following Respiratory Viral Infection#337060bioRxiv / medRxiv
• Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19#353333ClinicalTrials.gov
• Multiple, but not isolated, yellow fever virus-associated orthoflavivirus immune histories drive antibody-dependent enhancement of Zika and dengue viruses#369720bioRxiv / medRxiv
• Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients#384270CiNii
• QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.#444869ClinicalTrials.gov
• A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children#451523ClinicalTrials.gov
• Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.#452341Lund University Publications
• Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression.#452918NCBI PubMed Central
• PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery#467585ClinicalTrials.gov
• Impact of Respiratory Syncytial Virus season evolution on antibody responses#470976WIReDSpace
• Comprehensive Glycoproteomics and Glycomics Study of N-Linked Glycans and N-Glycoproteins#492498ScholarWorks@GSU
• Treatment with saturating dose of conventional anti-CD28 monoclonal antibody well tolerated in pig acute myocardial infarction model#619753Deutsche Nationalbibliothek
• Radioimmunotherapy With 131I-L19SIP in Patients With Cancer#807234ClinicalTrials.gov
• In Vivo CAR-T for Refractory Graves' Disease#810410ClinicalTrials.gov
• A Study of MRG003 in Patients With Advanced Solid Tumors#812943ClinicalTrials.gov
• Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma#825004ClinicalTrials.gov
• Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer#828041ClinicalTrials.gov
• Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities#829633ClinicalTrials.gov
• Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations#833525ClinicalTrials.gov
• Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1#834398ClinicalTrials.gov
• Immunogenicity Study of S-OIV H1N1 Influenza Vaccine#836014ClinicalTrials.gov
• Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma#836632ClinicalTrials.gov
• Kinetics of B Cell Response in Infants Menjugate Vaccination#837418ClinicalTrials.gov
• JSKN022 in Subjects With Advanced Malignant Solid Tumors#855285ClinicalTrials.gov
• 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals#880482ClinicalTrials.gov
• Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma#883646ClinicalTrials.gov
• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus#885860ClinicalTrials.gov
• Tanezumab In Osteoarthritis Of The Knee (2)#892098ClinicalTrials.gov
• mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC#28309ClinicalTrials.gov
• PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer#121352ClinicalTrials.gov
• Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019#131030bioRxiv / medRxiv
• Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients#206193LSHTM Data Compass
• Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO#249726ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors#303748ClinicalTrials.gov
• Development and Miniaturization of Pad-Printed Carbon Electrodes for Antibody-Type Biosensing#321498BYU ScholarsArchive